Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Chinese Journal of Primary Medicine and Pharmacy ; (12): 1719-1723, 2017.
Artigo em Chinês | WPRIM | ID: wpr-511980

RESUMO

Objective To investigate the clinical efficacy and safety of intravenous inhalation of pumicillin,ventolin and ipratropine in the treatment of severe acute asthma exacerbations in adults.Methods 78 adult patients with severe asthma were randomly divided into research group and control group by the method of random number table.The patients in the control group received routine treatment,it was intravenous infusion of methylprednisolone.On the basis of the above, the research group received intravenous inhalation of pumicil.The clinical efficacy,methylprednisolone use and use of time,asthma symptoms score,the disappearance of asthma symptoms and the incidence of adverse reactions of the two groups were observed and compared.Results The effective rate of the research group was 97.44% (38/39),which was higher than 82.05% (32/39) of the control group (x2=5.014,P0.05).Conclusion On the basis of intravenous medication,combined with pumicillin,ventolin and ipratropine triple inhalation in the treatment of severe asthma patients,can reduce the intravenous use of methylprednisolone,it was effective in patients with asthma symptoms,the clinical efficacy is significant,the clinical value is higher,it is worthy of promotion and application.

2.
China Pharmacy ; (12): 4055-4056,4057, 2015.
Artigo em Chinês | WPRIM | ID: wpr-605059

RESUMO

OBJECTIVE:To provide reference for rational drug use in elderly patients. METHODS:Retrieved from“Chinese Patent Medicine Prescription”of our hospital,the information of elderly drug use in 298 Chinese patent medicine package inserts were analyzed statistically. RESULTS:The item of“elderly drug use”had not been listed as a title and described in 298 package in-serts. Among 292 package inserts of non-special Chinese patent medicine for child and woman,there were 5 package inserts with“attention”and“contraindication”which described elderly drug use (1.71%),in which 2 package inserts pointed out the elderly should use Chinese patent medicine cautiously and 3 package inserts prompted the elderly should use Chinese patent medicine guid-ed by physicians. 287 package inserts of Chinese patent medicine didn’t stated any information of elderly drug use(98.29%). CON-CLUSIONS:The information of elderly drug use is defective seriously in package inserts of Chinese patent medicine. It can’t be used as guide for eldely drag se.

3.
Chinese Journal of Information on Traditional Chinese Medicine ; (12): 122-123, 2014.
Artigo em Chinês | WPRIM | ID: wpr-459141

RESUMO

Objective To provide the basis for making reasonable purchase plan, reserving TCM decoction pieces and guaranteeing clinical medication by analyzing the usage condition of the TCM decoction pieces from 2010 to 2012 in Jishuitan hospital. Methods Through analysis of the defined daily dose system (DDDs), defined daily dose and defined daily cost, the sales quantity, sales amount of the TCM decoction pieces and the top 10 ones in annual consumption amount from 2010 to 2012 were counted. Results The annual sales quantity and sales amount of the TCM decoction pieces had been growing from 2010 to 2012. During the three years, 7 of the top 10 decoction pieces were the same ones, and the DDDs had been growing and daily dose cost was stable. Conclusion Basically the usage of the TCM decoction pieces is reasonable. The annual analysis is important for the storage management of TCM decoction pieces.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA